RT-qPCR evaluation of MYD88, NLRP3, and NFκβ in GA 18.5 pup brains. by Adrienne J. Bradley (20861948)

Subjects:

Modified intensity and location of cortical layer marker proteins following Pg-OMV exposure <i>in utero.</i> by Adrienne J. Bradley (20861948)

Subjects:

Data for figures. by Adrienne J. Bradley (20861948)

Subjects:

Changes in AL (A) and SE (B) according to the treatment time estimation curve in patients given 0.125% atropine. by Zi-Rong Chen (9227618)

Subjects:

Table 2 - Early identification of the efficacy of 0.125% atropine treatment for children with Myopia: A prospective pilot study by Zi-Rong Chen (9227618)

Subjects:

Numbers of deaths and disability-adjusted life years (DALYs) by disease stage in China from 1990 to 2021. by Xinyue Qi (9637055)

Subjects:

Deaths and DALYs from hepatitis B-related liver diseases in 1990 and 2021 and their change trends from 1990 to 2021. by Xinyue Qi (9637055)

Subjects:

Contribution of acute hepatitis B, cirrhosis and other chronic diseases due to hepatitis B and liver cancer due to hepatitis B to deaths and DALYs of total liver diseases due to he... by Xinyue Qi (9637055)

Subjects:

Age-standardized mortality rates (ASMR), age-standardized disability-adjusted life year rates (ASDR), and their 95% uncertainty intervals (UIs) by disease stage in China from 1990... by Xinyue Qi (9637055)

Subjects:

BAPC model projections of mortality and DALYs rates for each disease stage in China from 2022 to 2035, with 50%, 60%, 70%, 80%, and 95% uncertainty intervals. by Xinyue Qi (9637055)

Subjects:

Predictions for the annual age-standardized disability-adjusted life years (ASDR) attributable to hepatitis B virus (HBV) infection in China until 2035 on the basis of the Bayesian... by Xinyue Qi (9637055)

Subjects:

Association between flavonoid intakes and metabolic dysfunction-associated steatotic liver disease (MASLD) using a Restricted Cubic Spline regression model, adjusted for age, sex,... by Yuwei He (1565941)

Subjects:

Top 20 IPA pathways of 1131 genes downregulated by compound 4f among genes upregulated following KA treatment with a <i>P</i>-value of < 0.05. by Naoto Arimura (416442)

Subjects:

Top 20 IPA pathways of 234 genes upregulated by compound 4f among genes downregulated following KA treatment with a <i>P</i>-value of < 0.05. by Naoto Arimura (416442)

Subjects:

Flow chart of animal experiment. by Shudan Liu (7049483)

Subjects:

EF-24 treatment induces distinct gene expression changes in Kasumi-1 cells. by Ajeet P. Singh (22298432)

Subjects:

CaCl₂ and MnCl₂ treatment significantly reduced Pol I occupancy on the rDNA template. by Abigail K. Huffines (20721555)

“…If the <i>p</i>-value < 0.05, that was deemed a significant difference between the two treatment groups and was indicated with either a green (increased occupancy) or black (decreased occupancy) line below the histogram for the CaCl₂ treated samples with respect to the untreated samples. …”

The effect of preservative treatments on average percentages of high molecular weight DNA (%HMW) and average yields of high molecular weight DNA normalized by tissue weight (nY) fo... by Ella Messner (14493059)

Subjects:

AUC of various models to predict imeglimin efficacy for liver function evaluated by ROC curves. by Naruyoshi Gyoutoku (22537831)

Subjects:

Logistic regression analysis to predict the efficacy for liver function. by Naruyoshi Gyoutoku (22537831)

Subjects: